Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Killestein

Showing results (11-20 of 89) with videos related to

Pageof 9
Sort By:
Neurology|October 10, 2007
Re: Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyC H Polman, F Deisenhammer, G Giovannoni, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 24, 2004
[Medicinal cannabis for diseases of the nervous system: no convincing evidence of effectiveness]J Killestein, P M Bet, A C van Loenen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 1, 2005
Sex differences in proinflammatory cytokine profiles of progressive patients in multiple sclerosisM J Eikelenboom, J Killestein, B M J Uitdehaag, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 29, 2014
Fingolimod-induced asthma deterioration in a patient with relapsing-remitting multiple sclerosisJ A van Rossum, E E Looysen, J M A Daniels, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 30, 2004
Multiple sclerosis following treatment with a cannabinoid receptor-1 antagonistB W van Oosten, J Killestein, E M H Mathus-Vliegen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 10, 2014
Disease course heterogeneity and OCT in multiple sclerosisL J Balk, P Tewarie, J Killestein, et al.
Neurology|November 30, 2011
Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosisO T Wiebenga, H E Hulst, E-J Kooi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 15, 2008
Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in womenJj Kragt, Bm van Amerongen, J Killestein, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 3, 2007
[Immunomodulatory therapy in multiple sclerosis]B M J Uitdehaag, B Jelles, J Killestein, et al.
Journal of the Neurological Sciences|August 7, 2009
Gender differences in multiple sclerosis: cytokines and vitamin DM J Eikelenboom, J Killestein, J J Kragt, et al.
Pageof 9

Showing results (11-20 of 89) with videos related to

Sort By:
Pageof 9
Neurology|October 10, 2007
Re: Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyC H Polman, F Deisenhammer, G Giovannoni, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 24, 2004
[Medicinal cannabis for diseases of the nervous system: no convincing evidence of effectiveness]J Killestein, P M Bet, A C van Loenen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 1, 2005
Sex differences in proinflammatory cytokine profiles of progressive patients in multiple sclerosisM J Eikelenboom, J Killestein, B M J Uitdehaag, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 29, 2014
Fingolimod-induced asthma deterioration in a patient with relapsing-remitting multiple sclerosisJ A van Rossum, E E Looysen, J M A Daniels, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 30, 2004
Multiple sclerosis following treatment with a cannabinoid receptor-1 antagonistB W van Oosten, J Killestein, E M H Mathus-Vliegen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 10, 2014
Disease course heterogeneity and OCT in multiple sclerosisL J Balk, P Tewarie, J Killestein, et al.
Neurology|November 30, 2011
Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosisO T Wiebenga, H E Hulst, E-J Kooi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 15, 2008
Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in womenJj Kragt, Bm van Amerongen, J Killestein, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 3, 2007
[Immunomodulatory therapy in multiple sclerosis]B M J Uitdehaag, B Jelles, J Killestein, et al.
Journal of the Neurological Sciences|August 7, 2009
Gender differences in multiple sclerosis: cytokines and vitamin DM J Eikelenboom, J Killestein, J J Kragt, et al.
Pageof 9